Off-target genomic DNA loci (RHO zinc-finger binding motif)

Off-target genomic DNA loci (RHO zinc-finger binding motif) refers to sequences within the human genome that share significant homology with the intended binding site of engineered zinc-finger proteins (ZFPs) designed to target the Rhodopsin (RHO) gene. These loci are of particular concern in the development of gene therapies for Retinitis Pigmentosa, such as ST-710, which utilizes zinc-finger transcription factors (ZFP-TFs) to repress RHO expression (Sangamo Therapeutics, 2024). While the ZFPs are engineered for high specificity, the inherent nature of DNA-binding domains allows for potential interaction with off-target sites that differ by only a few nucleotides from the consensus motif (Surace et al., 2012). Binding at these alternative genomic locations can lead to the unintended activation or repression of neighboring genes, potentially resulting in cellular toxicity or loss of function in retinal cells (Botta et al., 2016). Consequently, these loci are not therapeutic targets but represent critical safety liabilities that must be rigorously mapped using bioinformatic tools and experimental assays like ChIP-seq. Minimizing affinity for these sites is a primary goal in the optimization of ZFP-based therapeutics to ensure a high safety profile for clinical applications. The identification of these sites is essential for regulatory approval and patient safety monitoring in genetic medicine (Cradick et al., 2013).

Other names

RHO-ZFP off-target sitesZinc finger protein off-targetsNon-specific RHO binding sitesGenomic off-target loci

Engineered zinc-finger transcription factors (ZFP-TFs) bind to these loci due to sequence similarity with the intended RHO target, potentially causing unintended gene repression or activation (Botta et al., 2016).